Author: OMN AI

This article was created with the assistance of OMN AI, the AI-powered editorial platform developed by OMN Group. Every article is reviewed, fact-checked, and approved by a human journalist before publication to ensure accuracy and editorial quality. Learn more at https://omngroup.com

Agreement Unveiled at the White House President Donald Trump and Pfizer CEO Albert Bourla announced Tuesday that the pharmaceutical giant will provide lower prices on certain drugs to Medicaid programs nationwide. The White House described the arrangement as the first step toward applying “most-favored-nation” pricing, meaning states would be able to purchase new Pfizer medicines at the lowest price available in other developed countries. The administration also launched a new federal platform, TrumpRx, where discounted drugs will be offered. Pfizer Pledges Investments, Gains Tariff Relief In addition to the pricing agreement, Pfizer committed to investing roughly $70 billion in U.S.…

Read More

Donald Trump renewed his threat to impose a 100% tariff on all films produced outside the United States. He claimed the American film industry had been “stolen” by other countries. On Monday, he said California suffered particularly and that the tariff would “solve this long-time, never-ending problem.” In May, Trump said he planned to discuss the levy with Hollywood executives and begin its implementation. He warned that America’s film industry was dying “a very fast death.” His remarks followed a new wave of tariffs announced last week, including a 100% levy on branded or patented drug imports and 50% levies…

Read More

Parties Remain Divided on Funding PrioritiesA high-stakes meeting at the White House between President Donald Trump and congressional leaders ended without progress toward avoiding a government shutdown. Republicans pressed for a short-term funding bill free of policy riders, while Democrats demanded action on healthcare subsidies and other expiring protections before agreeing to extend federal spending. Deadline Approaches With No ResolutionWith only hours remaining before the midnight deadline, negotiations remain at a standstill. Vice President JD Vance warned that the government would shut down unless Democrats backed off their demands. Democrats countered that protecting healthcare coverage was nonnegotiable, setting the stage…

Read More

New Zealand’s only falcon, the kārearea, has soared to victory in the country’s annual Bird of the Year poll – in what organisers described as a rare, scandal-free contest. The tawny, sharp-taloned raptor, capable of reaching speeds of 200km/h in pursuit of prey, beat out 72 other contenders to secure the title. It marks the second time the species has won, after first taking the crown in 2012. With an estimated 5,000–8,000 birds left, the kārearea is considered threatened. It nests on the ground, leaving eggs vulnerable to introduced predators such as stoats, hedgehogs and cats. Habitat loss, collisions with…

Read More

Insider threats remain one of the most dangerous tools in cyber-crime. Few employees encounter them, and even fewer speak publicly about their experiences. I recently became one of those rare cases. A criminal group contacted me with a shocking proposal: betray my employer for millions. Sudden approach The first message arrived out of the blue. “If you are interested, we can offer you 15% of any ransom payment if you give us access to your PC.” The sender called themselves Syndicate. They reached me in July via Signal, an encrypted messaging app. I did not know them, but I immediately…

Read More

Walk down any supermarket aisle in 2025 and you’ll find pastel-coloured cans promising calm, focus, or energy. These so-called functional beverages – infused with ingredients like ashwagandha, lion’s mane mushrooms, magnesium, or L-theanine – have become a staple of the wellness market. Their rise is part of a cultural shift away from alcohol, with almost half of young people in the UK now choosing low- or non-alcoholic alternatives. “Functional drinks fit perfectly into today’s wellness culture,” says dietitian Nicolle Cucco. “People are more aware of their mental and physical health and are seeking convenient solutions. In a fast-paced world, the…

Read More

Donald Trump has ordered federal troops to Portland, Oregon, authorising the use of full force if necessary to control protests at immigration detention centres. The president said the deployment would protect federal facilities from attacks by Antifa and other domestic threats. He described the city as war-ravaged in a Truth Social post. The move expands federal troop presence in US cities as part of his broader crackdown on illegal immigration. democratic leaders criticise deployment Democratic officials condemned the decision, saying Portland faces no threat that requires federal intervention. Oregon Governor Tina Kotek described communities as calm and safe. She warned…

Read More

Jennifer Lawrence became the youngest recipient of the Donostia Award at the San Sebastian International Film Festival, receiving the honor at age 35. The Oscar-winning actress used the moment to speak out on politics and culture, warning that “our freedom of speech is under attack in America, including in the world of film.” Lawrence presented her latest project Kill Me Love, which she also produced, and encouraged young filmmakers to persevere: “Learn, go to casting tests, keep trying. But above all, watching films is very important.” She praised creators like Greta Gerwig for showing how female voices enrich cinema when…

Read More

Jaguar Land Rover has launched a phased restart of operations following a severe cyber-attack. Some IT systems are back online, and the company is clearing overdue supplier payments with enhanced invoicing capacity. Cyber-attack halts production The August attack forced Jaguar Land Rover to shut down IT networks and suspend car production. Factories will remain closed until at least next month. The prime minister said the government is working nonstop on a support package for suppliers. Smaller firms in the supply chain risk collapse if the shutdown continues. Opposition leader Sir Keir Starmer described the situation as urgent but admitted no…

Read More

A Cambridge-led clinical trial has raised hopes for a new class of multiple sclerosis (MS) treatments after finding that a combination of a diabetes drug and an antihistamine could partially repair nerve damage. The CCMR Two trial tested metformin, widely used for type 2 diabetes, alongside clemastine, an antihistamine previously linked to myelin repair. Seventy patients with relapsing MS were recruited, with half receiving the drug combination and half a placebo for six months. Researchers measured the speed of electrical signals between the eyes and brain, which are slowed in MS due to damaged myelin sheaths around nerves. Patients on…

Read More